Table 4.
Patient No. | Predictors of choledocholithiasis |
Confirmed choledocholithiasis | |||||||
---|---|---|---|---|---|---|---|---|---|
CBDS on US | clinical ascending cholangitis | total bilirubin >4 mg/dL | CBD dilation >6 mm on US | total bilirubin 1.8–4 mg/dL | abnormal liver test results | age >55 years | gallstone pancreatitis | ||
1 | X | X | Y | ||||||
2 | X | X | X | X | X | N | |||
3 | X | X | X | X | Y | ||||
4 | X | X | X | N | |||||
5 | X | X | X | X | X | N | |||
6 | X | X | X | X | Y | ||||
7 | X | X | X | Y | |||||
8 | X | X | X | Y | |||||
9 | X | X | X | Y | |||||
10 | X | X | X | X | N | ||||
11 | X | X | X | N | |||||
12 | X | X | X | X | Y | ||||
13 | X | X | Y | ||||||
14 | X | X | X | X | X | N | |||
15 | X | X | X | X | N | ||||
16 | X | X | X | N | |||||
17 | X | X | X | N | |||||
18 | X | X | X | X | Y | ||||
19 | X | X | X | N | |||||
20 | X | X | Y | ||||||
21 | X | X | X | Y | |||||
22 | X | X | X | Y | |||||
23 | X | X | X | X | Y | ||||
24 | X | X | X | X | Y | ||||
25 | X | X | Y | ||||||
26 | X | X | X | X | Y | ||||
27 | X | X | X | N | |||||
28 | X | X | Y | ||||||
29 | X | X | X | N | |||||
30 | X | X | X | N | |||||
31 | X | X | N | ||||||
32 | X | X | X | X | X | X | N | ||
33 | X | X | X | X | Y | ||||
34 | X | X | N | ||||||
35 | X | N | |||||||
36 | X | X | X | X | N | ||||
37 | X | X | X | N | |||||
38 | X | X | X | N | |||||
39 | X | X | X | N | |||||
40 | X | X | X | X | N |
CBD(S), common bile duct (stone); US, ultrasound; Y, yes; N, no.